A 3-year lifestyle intervention for adults at moderate to high risk of cardiovascular disease may be cost-effective when added to standard care and improves 3-year physical-function and bodily pain scores.

摘要

In this study, Eriksson and colleagues provide the QOL and cost-effectiveness data as part of a subanalysis of the Swedish Bjorknas study.' The Bjorknas study was a 3-year randomised controlled trial with lifestyle interventions performed in a primary care centre. It included a population at moderate-to-high risk for cardiovascular disease and reported reducing risk factors, including waist circumference, waist-to-hip ratio, blood pressure and smoking, while improving fitness. On the basis of these results, the study investigators hypothesised that the programme would also improve self-reported QOL and was cost-effective.